This notion is strongly supported by findings of significantly decreased testosterone and enhanced LH and FSH levels, which parallel the progression of CKD, which failed to correct after human chorionic gonadotropin (hCG) administration both in uremic rats and humans [24]. This evidence concerns the gene PLOD1 and chronic kidney disease.